What Researchers Did
Researchers reviewed the medical records of 135 patients who received hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss.
What They Found
The study, reviewing 135 patient records, found that hyperbaric oxygen therapy as an adjunctive treatment improved hearing in patients with idiopathic sudden sensorineural hearing loss. Early treatment is important, with HBO2 therapy recommended particularly within 14 days of onset.
What This Means for Canadian Patients
Canadian patients experiencing sudden sensorineural hearing loss may benefit from hyperbaric oxygen therapy as an adjunctive treatment. Seeking this therapy promptly, ideally within 14 days of onset, could improve their hearing outcomes.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
As a retrospective review of medical records, this study may be subject to inherent limitations such as selection bias or lack of a control group.